Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation

INTRODUCTION: Haematopoietic stem cell transplantation (HSCT) is commonly employed in the management of haematological malignancies. This intervention results in an increased risk of infectious and immune-related complications. Prophylactic immunoglobulin therapy has been used to prevent post-HSCT c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Juthaporn, Cameron, D W, Knoll, Greg, Tay, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550736/
https://www.ncbi.nlm.nih.gov/pubmed/26297369
http://dx.doi.org/10.1136/bmjopen-2015-008316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550736/
https://www.ncbi.nlm.nih.gov/pubmed/26297369
http://dx.doi.org/10.1136/bmjopen-2015-008316

Ejemplares similares